|
|
Effect of Articular Neurotoxin on Joint Pain and Neurochemical Signature |
| RX-000379-05 |
KRUG, HOLLIS E |
VA |
2020 |
|
|
Impact of Comorbidities on Stroke Outcomes and Treatments |
| RX-001141-05-A1 |
TOMLINSON, STEPHEN |
VA |
2020 |
|
|
Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis |
| RX-001180-01-A2 |
SERRA, ALESSANDRO |
VA |
2020 |
|
|
Bioactive injectable implants for functional intervertebral disc regeneration |
| RX-001321-06-A1 |
MAUCK, ROBERT |
VA |
2020 |
|
|
Resistive Training Combined with Nutritional Therapy after Stroke |
| RX-001461-01-A2 |
RYAN, ALICE S |
VA |
2020 |
|
|
Tissue-Engineered Constructs for Treatment of Intervertebral Disc Degeneration |
| RX-001476-01-A1 |
SMITH, HARVEY |
VA |
2020 |
|
|
Promoting adaptive neuroplasticity in mild cognitive impairment |
| RX-001534-01 |
HAMPSTEAD, BENJAMIN M |
VA |
2020 |
|
|
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures |
| RX-001613-01-A2 |
WAKADE, CHANDRAMOHAN |
VA |
2020 |
|
|
Amyloidopathy, cholinopathy, dopamine responsiveness and freezing of gait in PD |
| RX-001631-01-A2 |
BOHNEN, NICOLAAS I |
VA |
2020 |
|
|
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism |
| RX-001636-01-A1 |
YADAV, VIJAYSHREE |
VA |
2020 |
